Thymidylate Synthase Genotype-Directed Neoadjuvant Chemoradiation for Patients With Rectal Adenocarcinoma

PURPOSE: Downstaging (DS) of rectal cancers is achieved in approximately 45% of patients with neoadjuvant fluorouracil (FU) -based chemoradiotherapy (CRT). Polymorphisms in the thymidylate synthase gene (TYMS) had previously defined two risk groups associated with disparate tumor DS rates (60% v 22%...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tan, Benjamin R., Thomas, Fabienne, Myerson, Robert J., Zehnbauer, Barbara, Trinkaus, Kathryn, Malyapa, Robert S., Mutch, Matthew G., Abbey, Elliot E., Alyasiry, Amer, Fleshman, James W., McLeod, Howard L.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2011
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3068061/
https://ncbi.nlm.nih.gov/pubmed/21205745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.32.3212
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars